CDY 1.43% 7.1¢ cellmid limited

Comparisons, Connections & Conspiracy Theories, page-358

  1. 673 Posts.
    lightbulb Created with Sketch. 54

    Thanks T7. There is presently no clear buy signal. The contrarian approach would likely be behind a buy decision in the foreseeable future by either a despondent or optimist.

    The one fact the chart presents in plain view without need for interpretation is the horrible sp performance over 7 years. We all bitterly know this from the destruction of value of our CDY investments generally between 30% and 90%.

    This obliteration of market cap has been during the oversight of the incumbent CEO and Chairman who have said virtually nothing and appear to not care less.

    This is jeopardising the company’s capital management options going forward, impinges the Evolis expansion plans and Midkine partnership intentions. Forget the usual optimism touted here for better outcomes in the next half yearly report, the next quarterly and the annual report. Structural change is warranted for a sustainable future.

    It’s high time for the directors to step up to their statutory duties. Replacement of the Chairman with an independently minded, relevantly experienced Chair less influenced by the CEO would be a sensible agenda item for your next Board meeting gentlemen.
 
watchlist Created with Sketch. Add CDY (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.